Applied Statistics
World Generic Medicines Congress Americas 2012
Hyatt Regency Washington on Capitol Hill
400 New Jersey Avenue, NW
Washington, DC
World Generic Medicines Congress Americas 2012 
World Generic Medicine Congress
Hyatt Regency Washington on Capitol Hill
Hyatt Regency Washington on Capitol Hill

Schedule of Presentations:

Tuesday, November 27, 2012
Wednesday, November 28, 2012
06:00:00 Deep dive review of the generic and biosimilars industry and opportunities in China
08:00:00 Registration
08:45:00 Opening remarks from the chair
09:00:00 The role of generic medicines in the delivery of affordable and effective medicine to patients
09:30:00 Building value and a successful generics portfolio with a focus on Europe
10:00:00 Generic growth strategies through innovative partnering models
10:30:00 Morning refreshments & Speed networking
11:30:00 Update of US Health Care Reform and impact of recent US legislation on generics Juliana Reed
12:00:00 Key FTC actions affecting the generics industry Mark Woodward
12:30:00 Legal and patent strategies for the generics industry Stephen Auten
13:00:00 Lunch+ Lunch sessions
14:00:00 M&A environment and opportunities for generic companies Robert Steininger
14:30:00 Challenges for the industry: pricing and competition
15:00:00 Long term growth strategies for generic manufacturers Carole S. Ben-Maimon
15:30:00 Afternoon refreshments
16:00:00 Overcoming Obstacles in the Supply Chain
16:30:00 In conversation session: innovation ain generic marketing and sales – demand generation for branded generics Richard DiCicco
17:00:00 Market Dynamics in Southern Africa: The Good, The bad and The Ugly' George Proctor
18:00:00 Closing remarks followed by the networking drinks reception
Thursday, November 29, 2012
08:45:00 Opening remarks from the chair
09:00:00 Congressional update and Q&A session on US Legislation
09:30:00 Panel session: USA current and future regulatory setting for biosimilars Carrie Burke, F. Owen Fields
10:30:00 Morning refreshments
11:00:00 The global biosimilar industry of today: considerations and expectations
11:30:00 Business models for commercial success in biosimilars
12:00:00 Operational realities of building a biosimilar and biobetter development strategy
12:30:00 Lunch
13:30:00 USA market access for generic medicines: a focus on reimbursement trends from Medicaid & Medicare. Richard Gilfillan
14:00:00 Influence of generic medicines on evolutionary changes in pharmaceutical trade and wholesaling industry
14:15:00 Panel discussion: What is driving the purchasing decisions for generic medicines in the US?
14:45:00 Afternoon refreshments
15:15:00 MENA Pharma markets new post Arab spring
15:45:00 Cancer drug shortages: how can the generics sector help overcome the challenges Bruce Chabner
16:15:00 Challenges and opportunities in gaining market share from a smaller generic manufacturer perspective
16:45:00 Forecasting to aid strategic portfolio management
17:15:00 Closing remarks from the chair
17:20:00 End of conference
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.